FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Odan Laboratories Day Cream SPF15 Cr¿me de jour FPS 15 Recall

Day Cream SPF15 Cr¿me de jour FPS 15, { Avobenzone 2%, Octinoxate 7%, Oxybenzone 5%} 1…

Odan Laboratories Ltd · Pointe-Claire, N/A

Risk level
Class II
Reported by FDA
Jan 31, 2018
Recall ID
D-0231-2018
Check your lot numberHow we source this data

Summary

Odan Laboratories recalled Day Cream SPF15 Cr¿me de jour FPS 15 starting Dec 20, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0231-2018 on Jan 31, 2018. Reason: Failed Stability Specifications:stability failure at 12 months, long term RT conditions. Status: Terminated.

Why it was recalled

Failed Stability Specifications:stability failure at 12 months, long term RT conditions.

Product description

Day Cream SPF15 Cr¿me de jour FPS 15, { Avobenzone 2%, Octinoxate 7%, Oxybenzone 5%} 15 ml / 0.5 fl. oz jar. Made in Canada, Kamins Dermatologics Inc. Montreal, Quebec H9R 2Y6. Distributed by Kamins Dermatologics Montreal, Quebec H9R 2Y6 Made in Fabrique au Canada. UPC code 6 26354 10955 0

Lot numbers, UPCs & expiration codes

Lot # J146C, EXP 02-2019.

Where it was sold

distributed nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0231-2018
Classification
Class II
Status
Terminated
Recall initiated
Dec 20, 2017
FDA report date
Jan 31, 2018
Quantity
21 jars
Recall type
Voluntary: Firm initiated
Recalling firm
Odan Laboratories Ltd

Original FDA data

Every field from FDA enforcement report D-0231-2018, exactly as published.

Show all FDA fields
City
Pointe-Claire
Status
Terminated
Country
Canada
Event ID
78887
Address
325 Stillview Ave
Code information
Lot # J146C, EXP 02-2019.
Report date
Jan 31, 2018
Product type
Drugs
Recall number
D-0231-2018
Classification
Class II
Recalling firm
Odan Laboratories Ltd
Product quantity
21 jars
Termination date
Jun 18, 2018
Reason for recall
Failed Stability Specifications:stability failure at 12 months, long term RT conditions.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Day Cream SPF15 Cr¿me de jour FPS 15, { Avobenzone 2%, Octinoxate 7%, Oxybenzone 5%} 15 ml / 0.5 fl. oz jar. Made in Canada, Kamins Dermatologics Inc. Montreal, Quebec H9R 2Y6. Distributed by Kamins Dermatologics Montreal, Quebec H9R 2Y6 Made in Fabrique au Canada. UPC code 6 26354 10955 0
Distribution pattern
distributed nationwide in the USA
Recall initiation date
Dec 20, 2017
Initial firm notification
Letter
Center classification date
Jan 24, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0231-2018, published Jan 31, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls